Influenza vaccine
203 results
101 - 200
Influenza Immunization and Chemoprophylaxis
Vaccination Guidelines for Diabetes- Pneumonia, Community-acquired (Pediatric)
- Palivizumab
Rotavirus vaccine- Rotavirus vaccine
- Streptococcus pneumoniae
- Pneumococcal vaccines
- Pneumococcal vaccines
- Influenza, Avian
- Baloxavir
- Haemophilus species
- Influenza
Health Alert Network (HAN)- Increased Respiratory Virus Activity, Especially Among Children, Early in the 2022-2023 Fall and Winter - Health Alert Network (HAN) No. 479
- Guidance for Clinicians Caring for Individuals Recently Evacuated from Afghanistan - Health Alert Network (HAN) No. 452
- Elevated Influenza Activity: Influenza B/Victoria and A(H1N1)pdm09 Viruses are the Predominant Viruses - Health Alert Network (HAN) No. 425
- Bacterial Meningitis, Adult Acute Community-acquired
- Amantadine
- Upper Respiratory Infections
- Zanamivir
- Oseltamivir
- Acute Otitis Media, Pediatric
- Haemophilus species
- Respiratory syncytial virus vaccines
- Pericarditis
- Japanese Encephalitis Virus
COVID-19 Vaccine Updates: Current Recommendations- Initial Evaluation
- Measles
- A COVID-19 Conversation - Variants, Vaccines, and Long-Term Effects
- Myocarditis
- Parainfluenza virus
- Screening for and Prevention of Infectious Diseases in Special Populations
- Preseptal Cellulitis and Orbital Cellulitis
- Meningococcal vaccines
- Epiglottitis
- Zoster vaccine
- Zoster vaccine
- HIV, Initial Evaluation
- Nirsevimab
- Otitis Media, Adult [acute otitis media and chronic otitis media]
- Diabetes and COVID-19
- Thrombocytopenia
- Aseptic Meningitis
- Parotitis
- Respiratory tract infections: In the returned traveler
- Routine Preventive Care
- Clostridium tetani (Tetanus)
- Neisseria meningitidis
- Neisseria meningitidis
- Respiratory syncytial virus
- Pneumonia, Community-Acquired (Adult)
- Mumps
- Pneumonia, bacterial
- Fever and Neutropenia
- Encephalitis
- Rhinovirus
- Coronavirus COVID-19 (SARS-CoV-2)
- Mastoiditis
- Fever in the returned traveler from tropical areas
- Coronavirus COVID-19 (SARS-CoV-2)
- Human Metapneumovirus
- Adenovirus
- Bronchiectasis
- Anthrax
- Chloroquine
- Streptococcus pyogenes (Group A)